{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T05:12:06Z","timestamp":1791090726831,"version":"4.1.0"},"reference-count":31,"publisher":"Archives of Pathology and Laboratory Medicine","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,12,1]]},"abstract":"<jats:p>Renal medullary carcinoma, also referred to as the seventh sickle cell nephropathy, typically affects young African Americans with sickle cell trait, or, less frequently, patients with sickle cell disease. The existence of renal medullary carcinoma without a concomitant hemoglobinopathy is a topic of controversy. The typical patient is a young male of African or Mediterranean descent, with hematuria and\/or flank pain. Most patients have metastatic disease at the time of presentation. The tumor is characteristically a poorly circumscribed mass in the medullary region, commonly showing variable amounts of hemorrhage and necrosis. Microscopically, a characteristic reticular or cribriform pattern with a striking desmoplastic stromal response and a robust mixed inflammatory infiltrate is observed. Collecting duct carcinoma, malignant rhabdoid tumor, urothelial carcinoma, and other subtypes of renal cell carcinoma are in the differential diagnosis. Because of the advanced stage of disease at presentation and the aggressive nature of this malignant neoplasm, survival is poor even with chemotherapy; however, isolated reports of prolonged survival have been documented.<\/jats:p>","DOI":"10.5858\/arpa.2017-0492-rs","type":"journal-article","created":{"date-parts":[[2019,3,11]],"date-time":"2019-03-11T10:50:17Z","timestamp":1552301417000},"page":"1556-1561","source":"Crossref","is-referenced-by-count":33,"title":["Renal Medullary Carcinoma"],"prefix":"10.5858","volume":"143","author":[{"given":"Alexis","family":"Elliott","sequence":"first","affiliation":[{"name":"From the Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Bruner","sequence":"additional","affiliation":[{"name":"From the Department of Pathology and Laboratory Medicine, Medical University of South Carolina, Charleston."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"3906","published-online":{"date-parts":[[2019,3,11]]},"reference":[{"issue":"1","key":"2020081203362942100_i1543-2165-143-12-1556-b01","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00000478-199501000-00001","article-title":"Renal medullary carcinoma: the seventh sickle cell nephropathy","volume":"19","author":"Davis","year":"1995","journal-title":"Am J Surg Pathol"},{"key":"2020081203362942100_i1543-2165-143-12-1556-b02","article-title":"Renal medullary carcinoma","volume":"31","author":"Amin","year":"2016","journal-title":"WHO Classification of Tumours of the Urinary System and Male Genital Organs. 4th ed"},{"key":"2020081203362942100_i1543-2165-143-12-1556-b03","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.humpath.2017.07.006","article-title":"Renal cell carcinoma, unclassified with medullary phenotype: poorly differentiated adenocarcinomas overlapping with renal medullary carcinoma","volume":"67","author":"Sirohi","year":"2017","journal-title":"Hum Pathol"},{"issue":"10","key":"2020081203362942100_i1543-2165-143-12-1556-b04","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1001\/jama.1974.03230350051035","article-title":"Sickle cell nephropathy","volume":"228","author":"Berman","year":"1974","journal-title":"JAMA"},{"issue":"6","key":"2020081203362942100_i1543-2165-143-12-1556-b05","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0090-4295(02)02154-4","article-title":"Renal medullary carcinoma: clinical, pathologic, immunohistochemical and genetic analysis with pathogenetic implications","volume":"60","author":"Swartz","year":"2002","journal-title":"Urology"},{"issue":"4","key":"2020081203362942100_i1543-2165-143-12-1556-b06","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1097\/PAS.0b013e3182417d78","article-title":"Expression of OCT3\/4 in renal medullary carcinoma represents a potential diagnostic pitfall","volume":"36","author":"Rao","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"7","key":"2020081203362942100_i1543-2165-143-12-1556-b07","first-page":"1171","article-title":"Renal medullary carcinoma","volume":"98","author":"Baig","year":"2006","journal-title":"J Natl Med Assoc"},{"issue":"1","key":"2020081203362942100_i1543-2165-143-12-1556-b08","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1002\/cncr.20764","article-title":"Cytologic features of renal medullary carcinoma","volume":"105","author":"Assad","year":"2005","journal-title":"Cancer"},{"issue":"3","key":"2020081203362942100_i1543-2165-143-12-1556-b09","doi-asserted-by":"crossref","first-page":"e135","DOI":"10.5858\/2003-127-e135-RMCARO","article-title":"Renal medullary carcinoma: a report of 2 cases and review of the literature","volume":"127","author":"Dimashkieh","year":"2003","journal-title":"Arch Pathol Lab Med"},{"issue":"9","key":"2020081203362942100_i1543-2165-143-12-1556-b10","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1097\/PAS.0b013e3182635954","article-title":"Carcinoma of the collecting ducts of Bellini and renal medullary carcinoma: clinicopathologic analysis of 52 cases of rare aggressive subtypes of renal cell carcinoma with a focus on their interrelationship","volume":"36","author":"Gupta","year":"2012","journal-title":"Am J Surg Pathol"},{"issue":"10","key":"2020081203362942100_i1543-2165-143-12-1556-b11","doi-asserted-by":"crossref","first-page":"e47","DOI":"10.1097\/PAS.0b013e31822b325b","article-title":"INI1-deficient tumors: diagnostic features and molecular genetics","volume":"35","author":"Hollmann","year":"2011","journal-title":"Am J Surg Pathol"},{"issue":"3","key":"2020081203362942100_i1543-2165-143-12-1556-b12","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1365-2559.2012.04228.x","article-title":"SMARCB1\/INI1 inactivation in renal medullary carcinoma","volume":"61","author":"Calderaro","year":"2012","journal-title":"Histopathology"},{"issue":"6","key":"2020081203362942100_i1543-2165-143-12-1556-b13","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1038\/modpathol.2008.44","article-title":"Renal medullary carcinoma: rhabdoid features and the absence of INI1 expression as markers of aggressive behavior","volume":"21","author":"Cheng","year":"2008","journal-title":"Mod Pathol"},{"issue":"6","key":"2020081203362942100_i1543-2165-143-12-1556-b14","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1016\/j.eururo.2016.01.002","article-title":"SMARCB1\/INI1 genetic alterations in renal medullary carcinomas","volume":"69","author":"Lopez-Beltran","year":"2016","journal-title":"Eur Urol"},{"issue":"2","key":"2020081203362942100_i1543-2165-143-12-1556-b15","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/PAP.0000000000000138","article-title":"Clinicopathologic and molecular pathology of collecting duct carcinoma and related renal cell carcinomas","volume":"24","author":"Seo","year":"2017","journal-title":"Adv Anat Pathol"},{"issue":"6","key":"2020081203362942100_i1543-2165-143-12-1556-b16","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1016\/j.eururo.2015.09.027","article-title":"Balanced translocations disrupting SMARCB1 are hallmark recurrent genetic alterations in renal medullary carcinomas","volume":"69","author":"Calderaro","year":"2016","journal-title":"Eur Urol"},{"issue":"6","key":"2020081203362942100_i1543-2165-143-12-1556-b17","doi-asserted-by":"crossref","first-page":"e987","DOI":"10.1016\/j.clgc.2017.04.012","article-title":"Genomic characterization of renal medullary carcinoma and treatment outcomes","volume":"15","author":"Carlo","year":"2017","journal-title":"Clin Genitourin Cancer"},{"issue":"6","key":"2020081203362942100_i1543-2165-143-12-1556-b18","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1080\/01913120802591875","article-title":"Renal medullary carcinoma: ultrastructural studies may benefit diagnosis","volume":"32","author":"Wartchow","year":"2008","journal-title":"Ultrastruct Pathol"},{"issue":"4","key":"2020081203362942100_i1543-2165-143-12-1556-b19","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.path.2015.09.003","article-title":"Adult renal cell carcinoma: a review of established entities from morphology to molecular genetics","volume":"8","author":"Hirsch","year":"2015","journal-title":"Surg Pathol Clin"},{"issue":"8","key":"2020081203362942100_i1543-2165-143-12-1556-b20","doi-asserted-by":"crossref","first-page":"907","DOI":"10.5858\/arpa.2012-0196-CR","article-title":"High-grade carcinomas involving the renal sinus: report of a case and review of the differential diagnosis","volume":"136","author":"Young","year":"2012","journal-title":"Arch Pathol Lab Med"},{"issue":"3","key":"2020081203362942100_i1543-2165-143-12-1556-b21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1097\/PAS.0000000000001000","article-title":"Reappraisal of morphologic differences between renal medullary carcinoma, collecting duct carcinoma, and fumarate hydratase-deficient renal cell carcinoma","volume":"42","author":"Ohe","year":"2018","journal-title":"Am J Surg Pathol"},{"issue":"1","key":"2020081203362942100_i1543-2165-143-12-1556-b22","doi-asserted-by":"crossref","first-page":"92","DOI":"10.5858\/2010-0478-RAR.1","article-title":"Immunohistochemical diagnosis of renal neoplasms","volume":"135","author":"Truong","year":"2011","journal-title":"Arch Pathol Lab Med"},{"issue":"3\u20134","key":"2020081203362942100_i1543-2165-143-12-1556-b23","doi-asserted-by":"crossref","first-page":"e172","DOI":"10.5489\/cuaj.2373","article-title":"Clinical outcome and prognostic factors in renal medullary carcinoma. a pooled analysis from 18 years of medical literature","volume":"9","author":"Iacovelli","year":"2015","journal-title":"Can Urol Assoc J"},{"issue":"3","key":"2020081203362942100_i1543-2165-143-12-1556-b24","first-page":"e44","article-title":"Renal medullary carcinoma response to chemotherapy: a referral center experience in Brazil","volume":"5","author":"Maroja Silvino MC, Venchiarutti Moniz CM, Munhoz Piotto GH, Siqueira S, Galapo Kann A, Dzik C","year":"2013","journal-title":"Rare Tumors"},{"key":"2020081203362942100_i1543-2165-143-12-1556-b25","first-page":"615895","article-title":"Renal medullary carcinoma: case report of an aggressive malignancy with near-complete response to dose-dense methotrexate, vinblastine, doxorubicin, and cisplatin chemotherapy","volume":"2014","author":"Amjad","year":"2014","journal-title":"Case Rep Oncol Med"},{"key":"2020081203362942100_i1543-2165-143-12-1556-b26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40425-016-0206-1","article-title":"Clinical and immunologic correlates of response to PD-1 blockade in a patient with metastatic renal medullary carcinoma","volume":"5","author":"Beckermann","year":"2017","journal-title":"J Immunother Cancer"},{"issue":"1","key":"2020081203362942100_i1543-2165-143-12-1556-b27","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/s40425-017-0267-9","article-title":"Predictive role of PD-L1 expression in the response of renal medullary carcinoma to PD-1 inhibition","volume":"5","author":"Sodji","year":"2017","journal-title":"J Immunother Cancer"},{"issue":"4","key":"2020081203362942100_i1543-2165-143-12-1556-b28","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1002\/pbc.25832","article-title":"Is there a role for antiangiogenic therapy in renal medullary carcinoma?","volume":"63","author":"Batra","year":"2016","journal-title":"Pediatr Blood Cancer"},{"issue":"15S","key":"2020081203362942100_i1543-2165-143-12-1556-b29","doi-asserted-by":"crossref","first-page":"e16096","DOI":"10.1200\/jco.2009.27.15_suppl.e16096","article-title":"Survival benefit in bevacizumab-based therapy in sickle cell trait patients diagnosed with renal medullary carcinoma","volume":"27","author":"Johnson","year":"2009","journal-title":"J Clin Oncol"},{"issue":"19","key":"2020081203362942100_i1543-2165-143-12-1556-b30","doi-asserted-by":"crossref","first-page":"7922","DOI":"10.1073\/pnas.1303800110","article-title":"Durable tumor regression in genetically altered malignant rhabdoid tumors by inhibition of methyltransferase EZH2","volume":"110","author":"Knutson","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"2020081203362942100_i1543-2165-143-12-1556-b31","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1038\/modpathol.3800934","article-title":"Renal medullary carcinoma: report of seven cases from Brazil","volume":"20","author":"Watanabe","year":"2007","journal-title":"Mod Pathol"}],"container-title":["Archives of Pathology &amp; Laboratory Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/143\/12\/1556\/2468646\/arpa_2017-0492-rs.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/meridian.allenpress.com\/aplm\/article-pdf\/143\/12\/1556\/2468646\/arpa_2017-0492-rs.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,12,3]],"date-time":"2025-12-03T19:36:45Z","timestamp":1764790605000},"score":1,"resource":{"primary":{"URL":"https:\/\/aplm.kglmeridian.com\/view\/journals\/arpa\/143\/12\/article-p1556.xml"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,3,11]]},"references-count":31,"journal-issue":{"issue":"12","published-online":{"date-parts":[[2019,3,11]]},"published-print":{"date-parts":[[2019,12,1]]}},"URL":"https:\/\/doi.org\/10.5858\/arpa.2017-0492-rs","relation":{},"ISSN":["0003-9985","1543-2165"],"issn-type":[{"value":"0003-9985","type":"print"},{"value":"1543-2165","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,3,11]]}}}